Disability Progression in Multiple Sclerosis Patients Using Early First‐line Treatments
EUROPEAN JOURNAL OF NEUROLOGY（2022）
Key words
beta-interferon,disability progression,early treatment,glatiramer acetate,multiple sclerosis,observational studies,propensity score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined